Exhibit 1.01
BARCLAYS CAPITAL INC.
CITIGROUP GLOBAL MARKETS INC.
CREDIT SUISSE SECURITIES (USA) LLC
$ 750,000,000
AGILENT TECHNOLOGIES, INC.
$250,000,000 4.45% Senior Notes due
2012
$500,000,000 5.50% Senior Notes due
2015
Underwriting
Agreement
September 9, 2009
Barclays Capital Inc.
Citigroup Global Markets
Inc.
Credit Suisse Securities (USA)
LLC
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
c/o Citigroup Global Markets Inc.
388 Greenwich Street
New York, New York 10013
c/o Credit Suisse Securities (USA)
LLC
Eleven Madison Avenue
New York, New York
10010
Ladies and Gentlemen:
Agilent Technologies, Inc., a
Delaware corporation (the “Company”), proposes to issue
and sell to the several Underwriters listed in Schedule 1 hereto
(the “Underwriters”), for whom you are acting as
representatives (the “Representatives”), $250,000,000
principal amount of its 4.45% Senior Notes due 2012 (the
“2012 Notes”) and $500,000,000 principal amount of its
5.50% Senior Notes due 2015 (the “2015 Notes” and,
together with the 2012 Notes, the “Securities”).
The Securities will be issued pursuant to an Indenture dated as of
October 24, 2007 (the “Base Indenture”) between
the Company and U.S. Bank National Association, as trustee (the
“Trustee”), as supplemented by the Second Supplemental
Indenture, to be dated as of September 14, 2009, in respect of
the 2012 Notes (the “Second Supplemental Indenture”)
and by
the Third Supplemental Indenture, to be dated as
of September 14, 2009, in respect of the 2015 Notes (the
“Third Supplemental Indenture” and, together with the
Base Indenture, the “Indenture”).
The Company hereby confirms its
agreement with the several Underwriters concerning the purchase and
sale of the Securities, as follows:
1.
Registration
Statement . The Company has
prepared and filed with the Securities and Exchange Commission (the
“Commission”) under the Securities Act of 1933, as
amended, and the rules and regulations of the Commission
thereunder (collectively, the “Securities Act”), a
registration statement on Form S-3 (File No. 333-161799),
including a prospectus (the “Basic Prospectus”),
relating to the debt securities, including the Securities, to be
issued from time to time by the Company. The Company has also
filed, or proposes to file, with the Commission pursuant to
Rule 424 under the Securities Act a prospectus supplement
specifically relating to the Securities (the “Prospectus
Supplement”). The registration statement, as amended at
the time it becomes effective, including the information, if any,
deemed pursuant to Rule 430A, 430B or 430C under the
Securities Act to be part of the registration statement at the time
of its effectiveness (“Rule 430 Information”), is
referred to herein as the “Registration Statement”; and
as used herein, the term “Prospectus” means the Basic
Prospectus as supplemented by the prospectus supplement
specifically relating to the Securities in the form first used (or
made available upon request of purchasers pursuant to Rule 173
under the Securities Act) in connection with confirmation of sales
of the Securities and the term “Preliminary Prospectus”
means the preliminary prospectus supplement specifically relating
to the Securities together with the Basic Prospectus. Any
reference in this Agreement to the Registration Statement, the
Basic Prospectus, any Preliminary Prospectus or the Prospectus
shall be deemed to refer to and include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the
Securities Act, as of the effective date of the Registration
Statement or the date of such Preliminary Prospectus or the
Prospectus, as the case may be, and any reference to
“amend”, “amendment” or
“supplement” with respect to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include any documents filed after such date
under the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission thereunder
(collectively, the “Exchange Act”) that are deemed to
be incorporated by reference therein. Capitalized terms used
but not defined herein shall have the meanings given to such terms
in the Registration Statement and the Prospectus.
At or prior to the time when sales
of the Securities were first made (the “Time of Sale”),
the Company had prepared the following information (collectively,
the “Time of Sale Information”): a Preliminary
Prospectus dated September 9, 2009, and each
“free-writing prospectus” (as defined pursuant to
Rule 405 under the Securities Act) listed on Annex A hereto as
constituting part of the Time of Sale Information.
2.
Purchase of
the Securities by the Underwriters . (a) The
Company agrees to issue and sell the Securities to the several
Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set
forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase from the Company the
respective principal amount of Securities set forth opposite such
Underwriter’s name in Schedule 1 hereto at a price equal to
99.511% of the principal amount of the 2012 Notes
2
and 99.087% of the principal
amount of the 2015 Notes plus accrued interest, if any, from
September 14, 2009 to the Closing Date (as defined
below). The Company will not be obligated to deliver any of
the Securities except upon payment for all the Securities to be
purchased as provided herein.
(b)
The Company
understands that the Underwriters intend to make a public offering
of the Securities as soon after the effectiveness of this Agreement
as in the judgment of the Representatives is advisable, and
initially to offer the Securities on the terms set forth in the
Prospectus. The Company acknowledges and agrees that the
Underwriters may offer and sell Securities to or through any
affiliate of an Underwriter and that any such affiliate may offer
and sell Securities purchased by it to or through any
Underwriter.
(c)
Payment for and
delivery of the Securities will be made at the offices of Simpson
Thacher & Bartlett LLP, 2550 Hanover Street, Palo Alto,
California 94304 at 10:00 A.M., New York City time, on
September 14, 2009, or at such other time or place on the same
or such other date, not later than the fifth business day
thereafter, as the Representatives and the Company may agree upon
in writing. The time and date of such payment and delivery is
referred to herein as the “Closing Date”.
(d)
Payment for the
Securities shall be made by wire transfer in immediately available
funds to the account(s) specified by the Company to the
Representatives against delivery to the nominee of The Depository
Trust Company, for the account of the Underwriters, of one or more
global notes representing the Securities (collectively, the
“Global Note”), with any transfer taxes payable in
connection with the sale of the Securities duly paid by the
Company. The Global Note will be made available for
inspection by the Representatives not later than 1:00 P.M.,
New York City time, on the business day prior to the Closing
Date.
(e)
The Company
acknowledges and agrees that the Underwriters are acting solely in
the capacity of an arm’s length contractual counterparty to
the Company with respect to the offering of Securities contemplated
hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an
agent of, the Company or any other person. Additionally,
neither the Representatives nor any other Underwriter is advising
the Company or any other person as to any legal, tax, investment,
accounting or regulatory matters in any jurisdiction. The
Company shall consult with its own advisors concerning such matters
and shall be responsible for making its own independent
investigation and appraisal of the transactions contemplated
hereby, and the Underwriters shall have no responsibility or
liability to the Company with respect thereto. Any review by the
Underwriters of the Company, the transactions contemplated hereby
or other matters relating to such transactions will be performed
solely for the benefit of the Underwriters and shall not be on
behalf of the Company.
3.
Representations and
Warranties of the Company . The Company
represents and warrants to each Underwriter that:
(a)
Preliminary
Prospectus . No order preventing
or suspending the use of any Preliminary Prospectus has been issued
by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with
the
3
Securities Act
and did not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading;
provided that the Company makes no representation and
warranty with respect to any statements or omissions made in
reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Preliminary
Prospectus.
(b)
Time of Sale
Information . The Time of Sale
Information, at the Time of Sale did not, and at the Closing Date
will not, contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading; provided that the Company makes no
representation and warranty with respect to any statements or
omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in
such Time of Sale Information. No statement of material fact
included in the Prospectus has been omitted from the Time of Sale
Information and no statement of material fact included in the Time
of Sale Information that is required to be included in the
Prospectus has been omitted therefrom.
(c)
Issuer Free
Writing Prospectus . The Company
(including its agents and representatives, other than the
Underwriters in their capacity as such) has not prepared, made,
used, authorized, approved or referred to and will not prepare,
make, use, authorize, approve or refer to any “written
communication” (as defined in Rule 405 under the
Securities Act) that constitutes an offer to sell or solicitation
of an offer to buy the Securities (each such communication by the
Company or its agents and representatives (other than a
communication referred to in clauses (i) (ii) and
(iii) below) an “Issuer Free Writing Prospectus”)
other than (i) any document not constituting a prospectus
pursuant to Section 2(a)(10)(a) of the Securities Act or
Rule 134 under the Securities Act, (ii) the Preliminary
Prospectus, (iii) the Prospectus, (iv) the documents
listed on Annex A hereto as constituting the Time of Sale
Information and (v) any electronic road show or other written
communications, in each case approved in writing in advance by the
Representatives. Each such Issuer Free Writing Prospectus
complied in all material respects with the Securities Act, has been
or will be (within the time period specified in Rule 433)
filed in accordance with the Securities Act (to the extent required
thereby) and, when taken together with the Preliminary Prospectus
accompanying, or delivered prior to delivery of, or filed prior to
the first use of, such Issuer Free Writing Prospectus, did not, and
at the Closing Date will not, contain any untrue statement of a
material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that
the Company makes no representation and warranty with respect to
any statements or omissions made in each such Issuer Free Writing
Prospectus in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in
any Issuer Free Writing Prospectus.
4
(d)
Registration
Statement and Prospectus . The Registration
Statement is an “automatic shelf registration
statement” as defined under Rule 405 of the Securities
Act that has been filed with the Commission not earlier than three
years prior to the date hereof; and no notice of objection of the
Commission to the use of such registration statement or any
post-effective amendment thereto pursuant to
Rule 401(g)(2) under the Securities Act has been received
by the Company. No order suspending the effectiveness
of the Registration Statement has been issued by the Commission and
no proceeding for that purpose or pursuant to Section 8A
of the Securities Act against the Company or related to the
offering has been initiated or threatened by the Commission; as of
the applicable effective date of the Registration Statement and any
amendment thereto, the Registration Statement complied and will
comply in all material respects with the Securities Act and the
Trust Indenture Act of 1939, as amended, and the rules and
regulations of the Commission thereunder (collectively, the
“Trust Indenture Act”), and did not and will not
contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order
to make the statements therein not misleading; and as of the date
of the Prospectus and any amendment or supplement thereto and as of
the Closing Date, the Prospectus will not contain any untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided that the Company
makes no representation and warranty with respect to (i) that
part of the Registration Statement that constitutes the Statement
of Eligibility and Qualification (Form T-1) of the Trustee
under the Trust Indenture Act or (ii) any statements or
omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in
the Registration Statement and the Prospectus and any amendment or
supplement thereto.
(e)
Incorporated
Documents . The documents
incorporated by reference in the Registration Statement, the
Prospectus and the Time of Sale Information, when they were filed
with the Commission conformed in all material respects to the
requirements of the Exchange Act and none of such documents
contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances
under which they were made, not misleading; and any further
documents so filed and incorporated by reference in the
Registration Statement, the Prospectus or the Time of Sale
Information, when such documents are filed with the Commission will
conform in all material respects to the requirements of the
Exchange Act and will not contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading.
(f)
Financial
Statements . The financial
statements and the related notes thereto included or incorporated
by reference in the Registration Statement, the Time of Sale
Information and the Prospectus comply in all material respects with
the applicable requirements of the Securities Act and the Exchange
Act, as applicable, and present fairly the financial position of
the Company and its subsidiaries as of the dates indicated and the
results of their operations and the changes in their cash flows for
the periods
5
specified; such
financial statements have been prepared in conformity with
generally accepted accounting principles applied on a consistent
basis throughout the periods covered thereby (expect as noted in
the Registration Statement with respect to the misclassification of
U.S. deferred tax valuation allowances and certain deferred tax
assets/deferred tax liabilities on the balance sheet for the fiscal
year ended October 31, 2008, due to the misapplication of the
jurisdictional netting requirements of Statement on Financial
Accounting Standards No. 109 (“SAB No. 109”),
and the subsequent reclassification thereof to comply with SAB
No. 109), and the supporting schedules included or
incorporated by reference in the Registration Statement present
fairly the information required to be stated therein; and the other
financial information included or incorporated by reference in the
Registration Statement, the Time of Sale Information and the
Prospectus has been derived from the accounting records of the
Company and its subsidiaries and presents fairly the information
shown thereby.
(g)
No Material
Adverse Change . Since the date of the
most recent financial statements of the Company included or
incorporated by reference in the Registration Statement, the Time
of Sale Information and the Prospectus, (i) there has not been
any change in the capital stock or long-term debt of the Company or
any of its subsidiaries, or any dividend or distribution of any
kind declared, set aside for payment, paid or made by the Company
on any class of capital stock, or any material adverse change, or
any development involving a prospective material adverse change, in
or affecting the business, properties, management, financial
position, results of operations or prospects of the Company and its
subsidiaries taken as a whole (other than (x) the repurchase
of shares of Common Stock pursuant to the Company’s stock
repurchase program disclosed in the Registration Statement,
(y) the issuance of shares of common stock pursuant to the
Company’s equity compensation plans and (z) issuances of
capital stock by wholly-owned subsidiaries of the Company to the
Company or other wholly-owned subsidiaries of the Company or
repurchases of capital stock of wholly-owned subsidiaries of the
Company by the Company or other wholly-owned subsidiaries of the
Company); (ii) neither the Company nor any of its subsidiaries
has entered into any transaction or agreement that is material to
the Company and its subsidiaries taken as a whole or incurred any
liability or obligation, direct or contingent, that is material to
the Company and its subsidiaries taken as a whole; and
(iii) neither the Company nor any of its subsidiaries has
sustained any material loss or interference with its business from
fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor disturbance or dispute or any action,
order or decree of any court or arbitrator or governmental or
regulatory authority; except in each case as otherwise disclosed in
the Registration Statement, the Time of Sale Information and the
Prospectus.
(h)
Organization
and Good Standing . The Company and each
of its “significant subsidiaries”, as such term is
defined in Rule 1-02 of Regulation S-X under the Exchange Act
(the “Significant Subsidiaries”), have been duly
organized and are validly existing and in good standing under the
laws of their respective jurisdictions of organization, are duly
qualified to do business and are in good standing in each
jurisdiction in which their respective ownership or lease of
property or the conduct of their respective businesses requires
such qualification, and have all power and authority necessary to
own or hold their respective properties and to conduct the
businesses in
6
which they are
engaged, except where the failure to be so qualified, in good
standing or have such power or authority would not, individually or
in the aggregate, have a material adverse effect on the business,
properties, management, financial position, results of operations
or prospects of the Company and its subsidiaries taken as a whole
or on the performance by the Company of its obligations under the
Securities (a “Material Adverse Effect”). The
subsidiaries listed in Exhibit 21 to the Company’s
Annual Report on Form 10-K for its fiscal year ended
October 31, 2008 are the only significant subsidiaries of the
Company.
(i)
Capitalization
. All the
outstanding shares of capital stock or other equity interests of
each subsidiary of the Company have been duly and validly
authorized and issued, are fully paid and non-assessable (except,
in the case of any foreign subsidiary, for directors’
qualifying shares and except as otherwise described in the
Registration Statement, the Time of Sale Information and the
Prospectus) and are owned directly or indirectly by the Company
(except as disclosed in the Registration Statement, the Time of
Sale Information and the Prospectus), free and clear of any lien,
charge, encumbrance, security interest, restriction on voting or
transfer or any other claim of any third party.
(j)
Due
Authorization . The Company has full
right, power and authority to execute and deliver this Agreement,
the Securities and the Indenture (collectively, the
“Transaction Documents”) and to perform its obligations
hereunder and thereunder; and all action required to be taken for
the due and proper authorization, execution and delivery of each of
the Transaction Documents and the consummation of the transactions
contemplated thereby has been duly and validly taken.
(k)
The
Indenture . The Base Indenture
(i) has been duly authorized by the Company and duly executed
and delivered in accordance with its terms by each of the parties
thereto, (ii) constitutes a valid and legally binding
agreement of the Company enforceable against the Company in
accordance with its terms, except as enforceability may be limited
by applicable bankruptcy, insolvency or similar laws affecting the
enforcement of creditors’ rights generally or by equitable
principles relating to enforceability (collectively, the
“Enforceability Exceptions”) and (iii) upon
effectiveness of the Registration Statement was duly qualified
under the Trust Indenture Act. Each of the Second
Supplemental Indenture and the Third Supplemental Indenture has
been duly authorized by the Company and, when duly executed and
delivered in accordance with its terms by each of the parties
thereto, will have been duly qualified under the Trust Indenture
Act and will constitute a valid and legally binding agreement of
the Company enforceable against the Company in accordance with its
terms, subject to the Enforceability Exceptions.
(l)
The
Securities . The Securities have
been duly authorized by the Company and, when duly executed,
authenticated, issued and delivered as provided in the Indenture
and paid for as provided herein, will be duly and validly issued
and outstanding and will constitute valid and legally binding
obligations of the Company enforceable against the Company in
accordance with their terms, subject to the Enforceability
Exceptions, and will be entitled to the benefits of the
Indenture.
7
(m)
Underwriting
Agreement . This Agreement has
been duly authorized, executed and delivered by the
Company.
(n)
Descriptions
of the Transaction Documents . Each Transaction
Document conforms in all material respects to the description
thereof contained in the Registration Statement, the Time of Sale
Information and the Prospectus.
(o)
No Violation
or Default . Neither the Company
nor any of its subsidiaries is (i) in violation of its charter
or by-laws or similar organizational documents; (ii) in
default, and no event has occurred that, with notice or lapse of
time or both, would constitute such a default, in the due
performance or observance of any term, covenant or condition
contained in any indenture, mortgage, deed of trust, loan agreement
or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject; or (iii) in
violation of any law or statute or any judgment, order,
rule or regulation of any court or arbitrator or governmental
or regulatory authority, except, in the case of clauses
(ii) and (iii) above, for any such default or violation
that would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.
(p)
No
Conflicts . The execution,
delivery and performance by the Company of each of the Transaction
Documents, the issuance and sale of the Securities and compliance
by the Company with the terms thereof and the consummation of the
transactions contemplated by the Transaction Documents will not
(i) conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any of
its subsidiaries pursuant to, any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which the
Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries is bound or to which any of the
property or assets of the Company or any of its subsidiaries is
subject, (ii) result in any violation of the provisions of the
charter or by-laws or similar organizational documents of the
Company or any of its subsidiaries or (iii) result in the
violation of any law or statute or any judgment, order,
rule or regulation of any court or arbitrator or governmental
or regulatory authority, except, in the case of clauses
(i) and (iii) above, for any such conflict, breach,
violation or default that would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect.
(q)
No Consents
Required . No consent, approval,
authorization, order, registration or qualification of or with any
court or arbitrator or governmental or regulatory authority is
required for the execution, delivery and performance by the Company
of each of the Transaction Documents, the issuance and sale of the
Securities and compliance by the Company with the terms thereof and
the consummation of the transactions contemplated by the
Transaction Documents, except for the registration of the
Securities under the Securities Act, the qualification of the
Indenture under the Trust Indenture Act and such consents,
approvals, authorizations, orders and registrations or
8
qualifications as
may be required under applicable state securities laws in
connection with the purchase and distribution of the Securities by
the Underwriters.
(r)
Legal
Proceedings . Except as described
in the Registration Statement, the Time of Sale Information and the
Prospectus, there are no legal, governmental or regulatory
investigations, actions, suits or proceedings pending to which the
Company or any of its subsidiaries is a party or to which any
property of the Company or any of its subsidiaries is the subject
that, individually or in the aggregate, could reasonably be
expected to have a Material Adverse Effect; no such investigations,
actions, suits or proceedings are threatened or, to the knowledge
of the Company, contemplated by any governmental or regulatory
authority or threatened by others; and (i) there are no
current or pending legal, governmental or regulatory actions, suits
or proceedings that are required under the Securities Act to be
described in the Registration Statement or the Prospectus that are
not so described in the Registration Statement, the Time of Sale
Information and the Prospectus and (ii) there are no statutes,
regulations or contracts or other documents that are required under
the Securities Act to be filed as exhibits to the Registration
Statement or described in the Registration Statement and the
Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Time of
Sale Information and the Prospectus.
(s)
Independent
Accountants .
PricewaterhouseCoopers LLP, who have certified certain financial
statements of the Company and its subsidiaries is an independent
registered public accounting firm with respect to the Company and
its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting
Oversight Board (United States) and as required by the Securities
Act and the Exchange Act.
(t)
Title to Real
and Personal Property . The Company and its
subsidiaries have good and marketable title in fee simple to, or
have valid rights to lease or otherwise use, all items of real and
personal property that are material to the respective businesses of
the Company and its subsidiaries, in each case free and clear of
all liens, encumbrances, claims and defects and imperfections of
title except those that (i) do not materially interfere with
the use made and proposed to be made of such property by the
Company and its subsidiaries or (ii) could not reasonably be
expected, individually or in the aggregate, to have a Material
Adverse Effect.
(u)
Title to
Intellectual Property . To the knowledge of
the Company, (i) the Company and its subsidiaries own or
possess adequate rights to use all material patents, patent
applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, licenses,
domain names (in each case including all registrations and
applications to register same) and know-how (including trade
secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures)
(“Intellectual Property”) necessary for the conduct of
their respective businesses; (ii) there is no material
infringement of any such Intellectual Property by any third
parties; (iii) there is no pending or threatened action, suit,
proceeding or claim by any third party challenging the
Company’s or its subsidiaries’ rights in or to any such
Intellectual Property; (iv) there is no pending or threatened
action, suit, proceeding or
9
claim by any
third party challenging the validity, scope or enforceability of
any such Intellectual Property; (v) the conduct of
Company’s and its subsidiaries’ respective businesses
will not conflict in any material respect with any such rights of
others; and (vi) the Company and its subsidiaries have not
received any notice of any claim of infringement or conflict with
any such rights of others, except, in each case, where the same
would not reasonably be expected to have a Material Adverse
Effect.
(v)
No Undisclosed
Relationships . No relationship,
direct or indirect, exists between or among the Company or any of
its subsidiaries, on the one hand, and the directors, officers,
stockholders, customers or suppliers of the Company or any of its
subsidiaries, on the other, that is required by the Securities Act
to be described in the Registration Statement and the Prospectus
and that is not so described in such documents and in the Time of
Sale Information.
(w)
Investment
Company Act . The Company is not
and, after giving effect to the offering and sale of the Securities
and the application of the proceeds thereof as described in the
Registration Statement, the Time of Sale Information and the
Prospectus, will not be required to register as an
“investment company” or an entity
“controlled” by an “investment company”
within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission
thereunder (collectively, “Investment Company
Act”).
(x)
Taxes . Except as otherwise
disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, (i) the Company and its
subsidiaries have paid all federal, state, local and foreign taxes
and filed all tax returns required to be paid or filed through the
date hereof, and, except for such failures to pay or file as would
not individually or in the aggregate have a Material Adverse
Effect, (ii) there is no tax deficiency that has been, or
could reasonably be expected to be, asserted against the Company or
any of its subsidiaries or any of their respective properties or
assets, in each case that would, individually or in the aggregate,
have a Material Adverse Effect.
(y)
Licenses and
Permits . The Company and its
subsidiaries possess all licenses, certificates, permits and other
authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign
governmental or regulatory authorities that are necessary for the
ownership or lease of their respective properties or the conduct of
their respective businesses as described in the Registration
Statement, the Time of Sale Information and the Prospectus, except
where the failure to possess or make the same would not,
individually or in the aggregate, have a Material Adverse Effect;
and except as described in the Registration Statement, the Time of
Sale Information and the Prospectus, neither the Company nor any of
its subsidiaries has received notice of any revocation or
modification of any such license, certificate, permit or
authorization or has any reason to believe that any such license,
certificate, permit or authorization will not be renewed in the
ordinary course.
(z)
No Labor
Disputes . No labor disturbance
by or dispute with employees of the Company or any of its
subsidiaries exists or, to the knowledge of the Company, is
contemplated or threatened and the Company is not aware of any
existing or imminent
10
labor disturbance
by, or dispute with, the employees of any of its or its
subsidiaries’ principal suppliers, contractors or customers,
except as would not have a Material Adverse Effect.
(aa)
Compliance
With Environmental Laws . Except as otherwise
disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, (i) the Company and its
subsidiaries (x) are, and at all prior times were, in
compliance with any and all applicable federal, state, local and
foreign laws, rules, regulations, requirements, decisions and
orders relating to the protection of human health or safety, the
environment, natural resources, hazardous or toxic substances or
wastes, pollutants or contaminants (collectively,
“Environmental Laws”); (y) have received and are
in compliance with all permits, licenses, certificates or other
authorizations or approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and
(z) have not received notice of any actual or potential
liability under or relating to any Environmental Laws, including
for the investigation or remediation of any disposal or release of
hazardous or toxic substances or wastes, pollutants or
contaminants, and have no knowledge of any event or condition that
would reasonably be expected to result in any such notice, and
(ii) there are no costs or liabilities associated with
Environmental Laws of or relating to the Company or its
subsidiaries, except in the case of each of (i) and
(ii) above, for any such failure to comply, or failure to
receive required permits, licenses or approvals, or cost or
liability, as would not, individually or in the aggregate, have a
Material Adverse Effect; and (iii) except as described in each
of the Time of Sale Information and the Prospectus, (x) there
are no proceedings that are pending, or that are known to be
threatened, against the Company or any of its subsidiaries under
any Environmental Laws in which a governmental entity is also a
party, other than such proceedings regarding which it is reasonably
believed no monetary sanctions of $1,000,000 or more will be
imposed and (y) the Company and its subsidiaries are not
aware of any issues regarding compliance with Environmental Laws,
or liabilities or other obligations under Environmental Laws or
concerning hazardous or toxic substances or wastes, pollutants or
contaminants, that could reasonably be expected to have a material
adverse effect on the capital expenditures, earnings or competitive
position of the Company and its subsidiaries.
(bb)
Compliance
With ERISA . (i) Each
employee benefit plan, within the meaning of
Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”), for which the
Company or any member of its “Controlled Group”
(defined as any organization which is a member of a controlled
group of corporations within the meaning of Section 414 of the
Internal Revenue Code of 1986, as amended (the “Code”))
would have an
|